Mutational analysis of CYP2C8 in hypertensive patients using denaturing high performance liquid chromatography

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 6, 2010, Pages 723-728

  Teh, L K ^a   Zahri, M K ^a   Zakaria, Z A ^a   Ismail, R ^b   Salleh, M Z ^a  

^a UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^b INSTITUTE FOR RESEARCH IN MOLECULAR MEDICINE INFORMM   (Malaysia)

Author keywords

CYP2C8; denaturing high performance liquid chromatography (DHPLC); genetic polymorphism; hypertension; Malaysia; single nucleotide polymorphism (SNP)

Indexed keywords

CYSTEINE; CYTOCHROME P450 2C8; THREONINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE DELETION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ARYL HYDROCARBON HYDROXYLASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 ENZYME SYSTEM; DNA MUTATIONAL ANALYSIS; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; HYPERTENSION; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78449286775     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01146.x     Document Type: Article

References (16)

1. Rahman A, Korzekwa KR, Grogan J, Gonzalez FJ, Harris JW, (1994) Selective transformation of taxol to 6-alpha-hydroxytaxol by human cytocrome-P450 2C8. Cancer Research, 54, 5543-5546.
2. Yamazaki H, Shibata A, Suzuki M, Nakajima M, Shimada N, Guengerich FP, Yokoi T, (1999) Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes. Drug Metabolism and Disposition, 27, 1260-1266.
3. Baldwin SJ, Clarke SE, Chenery RJ, (1999) Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone. British Journal of Clinical Pharmacology, 48, 424-432.
4. Ohyama K, Nakajima M, Nakamura S, Shimada N, Yamazaki H, Yokoi T, (2000) A significant role of human cytochrome P4502C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. Drug Metabolism and Disposition, 28, 1303-1310.
5. Bahadur N, Leathart JBS, Mutch E, et al. (2002) CYP2C8 polymorphism in Caucasians and their relationship with paclitaxel 6α-hydroxylase activity in human liver microsomes. Biochemical Pharmacology, 64, 1579-1589.
6. Li X-Q, Bjorkman A, Andersson TB, Ridderstorm M, Masimirembwa CM, (2002) Amadiaquine clearance and its metabolism to N-desthylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate. Journal of Pharmacology and Experimental Therapeutics, 300, 399-407.
7. Yun CH, Shimada T, Guengerich FP, (1992) Roles of human liver cytochrome P4502C and cytochrome P4503A enzymes in the 3-hydroxylation of benzo(a)pyrene. Cancer Research, 52, 1868-1874.
8. Mutch E, Blain PG, Williams FM, (1999) The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicology Letters, 107, 177-187.
9. Zeldin DC, Dubois RN, Falck JR, Capdevila JH, (1995) Molecular cloning expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform. Archives of Biochemistry and Biophysics, 322, 76-86.
10. Dai D, Zeldin DC, Blasidell JA, Chanas B, Coulter SJ, Ghaneyem BI, Goldstein JA, (2001) Polymorphism in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics, 11, 597-607.
11. Nakajima M, Fujiki Y, Noda K, et al. (2003) Genetic polymorphisms of CYP2C8 in Japanese population. Drug Metabolism and Disposition, 31, 687-690.
12. Muthiah YD, Lee WL, Teh LK, Ong CE, Ismail R, (2004) A simple multiplex PCR method for the concurrent detection of three CYP2C8 variants. Clinica Chimica Acta, 349, 191-198.
13. Teh LK, Ismail R, Yusoff R, Hussein A, Isa MN, Rahman AR, (2001) Heterogeneity of the CYP2D6 gene among Malays in Malaysia. Journal of Clinical Pharmacy and Therapeutics, 26, 205-211.
14. Spiegelman JI, Mindrinos MN, Oefner PJ, (2000) High-accuracy DNA sequence variation screening by DHPLC. BioTechniques, 29, 1084-1090. 1092.
15. Jones AC, Austin J, Hansen N, Hoogendorn B, Oefner PJ, Cheadle JP, O'Donovan MC, (1999) Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis. Clinical Chemistry, 45, 1133-1140.
16. Dreisbach AW, Japa S, Sigel A, et al. (2005) The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension. American Journal of Hypertension, 18, 1276-1281.